Home › Mesothelioma › NCT03683680

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* All adult patients with a diagnosis of malignant pleural mesothelioma undergoing

  * diagnostic pleural biopsy
  * pleuroscopy
  * and/or VATS resections
* Participants must be 18 years of age or older.

Exclusion Criteria:

-Any patient who is found to be unsuitable for

* surgery,
* treatment
* diagnosis,

About the study

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

What is being tested

• MPT Test (other)
• CLDN15/VIM Test (other)

Sponsor: Dana-Farber Cancer Institute · Participants: 240 · Started: Oct 31, 2018

Contact the study team

• Raphael Bueno, MD · Phone: 617-732-5690

Official record on ClinicalTrials.gov — NCT03683680

Locations in the U.S.

Conditions

• Mesothelioma

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.